Bunge (BG) is close to getting a ruling from Chinese regulators on its $8.2B purchase of Glencore-backed (GLNCY) Viterra with a verdict expected within days, Bloomberg’s Isis Almeida and Hallie Gu report. Regulatory approval in China remains among the last remaining hurdles to the deal’s closing, as the deal has already received key approvals in the EU and Canada.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG: